Donald Hooker
Stock Analyst at Keybanc
(2.50)
# 2,118
Out of 5,182 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $5.75 | +1,639.13% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $169.80 | +129.68% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $196.27 | -13.38% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $162.28 | +78.70% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $9.54 | +665.20% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $3.51 | +925.64% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $5.88 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $161.13 | +119.08% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $82.45 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $65.47 | +28.30% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.13 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $263.80 | -35.56% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $102.17 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $0.91 | +4,967.75% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $410.54 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $5.75
Upside: +1,639.13%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $169.80
Upside: +129.68%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $196.27
Upside: -13.38%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $162.28
Upside: +78.70%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $9.54
Upside: +665.20%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $3.51
Upside: +925.64%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $5.88
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $161.13
Upside: +119.08%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $82.45
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $65.47
Upside: +28.30%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $3.13
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $263.80
Upside: -35.56%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $102.17
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $0.91
Upside: +4,967.75%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $410.54
Upside: -